FDA Adds Boxed Warning to Ocaliva to Reinforce Correct Dosing FDA Adds Boxed Warning to Ocaliva to Reinforce Correct Dosing

Obeticholic acid may be incorrectly dosed daily instead of weekly in patients with moderate to severe primary biliary cholangitis, increasing the risk for serious liver injury and death, the FDA says.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news